Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism

References

• FryeMASalloumIMBipolar disorder and comorbid alcoholism: prevalence rate and treatment considerationsBipolar Disord2006867768517156154
   PubMed Web of Science ®Google Scholar
• VornikLABrownESManagement of comorbid bipolar disorder and substance abuseJ Clin Psychiatry200667243016961421
   PubMed Web of Science ®Google Scholar
• BrownESManagement of comorbid bipolar disorder and substance abuseJ Clin Psychiatry200667Suppl 7243016961421
   PubMed Web of Science ®Google Scholar
• WeissRDTreating patients with bipolar disorder and substance dependence: Lessons learnedJ Subst Abuse Treat20042730731215610832
   PubMed Web of Science ®Google Scholar
• WeissRDGriffinMLJaffeeWBA “community-friendly” version of integrated group therapy for patients with bipolar disorder and substance dependence: A randomized controlled trialDrug Alcohol Depend200910421221919573999
   PubMed Web of Science ®Google Scholar
• FarrenCKMcElroySTreatment response of bipolar and unipolar alcoholics to an inpatient dual diagnosis programJ Affect Disord200810626527217707085
   PubMed Web of Science ®Google Scholar
• LanMJMcLoughlinGAGriffinJLMetabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorderMol Psychiatry20081426927918256615
   PubMed Web of Science ®Google Scholar
• KatoTMolecular neurobiology of bipolar disorder: a disease of ‘mood-stabilizing neurons’?Trends Neurosci20083149550318774185
   PubMed Web of Science ®Google Scholar
• CatapanoLAManjiHKG protein-coupled receptors in major psychiatric disordersBiochim Biophys Acta2007176897699317078926
   PubMed Web of Science ®Google Scholar
• GellerBCooperTBSunKDouble blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependencyJ Am Acad Child Adolesc Psychiatry1998371711789473913
   PubMed Web of Science ®Google Scholar
• BradyKTSonneSCThe relationship between substance abuse and bipolar disorderJ Clin Psychiatry199556Suppl 319247883738
   PubMed Web of Science ®Google Scholar
• BradyKTSonneSCAntonRBallengerJCValproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot studyJ Clin Psychiatry1995561181217883730
   PubMed Web of Science ®Google Scholar
• BradyKTMyrickHHendersonSCoffeySFThe use of divalproex in alcohol relapse prevention: a pilot studyDrug Alcohol Depend20026732333012127203
   PubMed Web of Science ®Google Scholar
• SalloumIMCorneliusJRDaleyDCKirisciLHimmelhochJMThaseMEEfficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled studyArch Gen Psychiatry200562374515630071
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationPractice guideline for the treatment of patients with substance use disorders2nd edition2006 Available from: http://wwwpsychorg/psych_pract/treatg/pg/prac_guide.cfm. Accessed on August 10, 2009.
   Google Scholar
• SattarSPValproate in the treatment of bipolar disorder and comorbid substance abuse: a 24-week open lable trialBiol Psychiatry20076146S
   Web of Science ®Google Scholar
• ReouxJPMalteCAFarrCLFergusonLCSaxonAJControlled trial of extended release divalproex sodium in alcohol dependent patients with subsyndromal psychiatric symptoms18Th annual meeting and symposium of the American Academy of Addiction Psychiatry (AAAP)2007Hotel Del Coronado, Coronado, CA, USA
   Google Scholar
• BryantAEIIIDreifussFEValproic acid hepatic fatalities. III. US experience since 1986Neurology1996464654698614514
   PubMed Web of Science ®Google Scholar
• Jimenez-RodriguezvilaMCaro-PatónACondeMSide-effects of sodium valproate, mainly related to its hepatic and pancreatic toxicityInt J Clin Pharmacol Res198662172242427459
   PubMedGoogle Scholar
• DreifussFESantilliNLangerDHSweeneyKPMolineKAMenanderKBValproic acid hepatic fatalities: a retrospective reviewNeurology1987373793853102998
   PubMed Web of Science ®Google Scholar
• DreifussFELangerDHHepatic considerations in the use of antiepileptic drugsEpilepsia198728Suppl 2S23S293121292
   PubMed Web of Science ®Google Scholar
• RubioGLópez-MuñozFAlamoCEffects of lamotrigine in patients with bipolar disorder and alcohol dependenceBipolar Disord20068283293
   Web of Science ®Google Scholar
• GuilleCSachsGClinical outcome of adjunctive topiramate treatment in a sample of refractory bipolar patients with comorbid conditionsProg Neuropsychopharmacol Biol Psychiatry2002261035103912452523
   PubMed Web of Science ®Google Scholar
• HugueletPMorand-CollombSEffect of topiramate augmentation on two patients suffering from schizophrenia or bipolar disorder with comorbid alcohol abusePharmacol Res20055239239416009565
   PubMed Web of Science ®Google Scholar
• PerugiGToniCFrareFEffectiveness of adjunctive gabapentin in resistant bipolar disorder: is it due to anxious-alcohol abuse comorbidityJ Clin Psychopharmacol20022258459112454558
   PubMed Web of Science ®Google Scholar
• VietaECalabreseJRGoikoleaJMRainesSMacfaddenWQuetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled studyBipolar Disord2007941342517547587
   PubMed Web of Science ®Google Scholar
• CalabreseJRKeckPEJrMacfaddenWA randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depressionAm J Psychiatry20051621351136015994719
   PubMed Web of Science ®Google Scholar
• ThaseMEMacfaddenWWeislerRHBOLDER II Study GroupEfficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study)J Clin Psychopharmacol20062660060917110817
   PubMed Web of Science ®Google Scholar
• LongoriaJBrownESPerantieDCBobadillaLNejtekVAQuetiapine for alcohol use and craving in bipolar disorderJ Clin Psychopharmacol20042410110214709960
   PubMed Web of Science ®Google Scholar
• BrownESNejtekVAPerantieDCBobadillaLQuetiapine in bipolar disorder and cocaine dependenceBipolar Disord2002440641112519101
   PubMed Web of Science ®Google Scholar
• BrownESNejtekVAPerantieDCRajan ThomasNRushAJCocaine and amphetamine use in patients with psychiatric illness: a randomized trial of typical antipsychotic continuation or discontinuationJ Clin Psychopharmacol20032338438812920415
   PubMed Web of Science ®Google Scholar
• SattarSPSchultzSKArndtSSoundyTPettyFLong-term adjunctive quetiapine may reduce substance use–a preliminary retrospective studySouth Dakota Med200760439441
   Google Scholar
• BrownESGarzaMCarmodyTJA randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disordersJ Clin Psychiatry20086970170518312058
   PubMed Web of Science ®Google Scholar
• MartinottiGAndreoliSDi NicolaMDi GiannantonioMSarchiaponeMJaniriLQuetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholicsHuman Psychopharmacol Clin Exp200823417424
   PubMed Web of Science ®Google Scholar
• BrownESJeffressJLigginJDGarzaMBeardLSwitching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazoleJ Clin Psychiatry20056675676015960570
   PubMed Web of Science ®Google Scholar
• DavisLLLiXGarnerCBiladeauJUstinovYUezatoADivalproex ER versus risperidone for bipolar disorder with comorbid substance use disorderWashington, DC161st Annual Meeting of the American Psychiatric AssociationMay 3–8, 2008
   Google Scholar
• FryeMAChirichignoJWMcKowenJA single-blind evaluation of divalproex sodium vs olanzapine for alcohol abuse relapse prevention in bipolar disorderDon Cesar Beach Resort, FLAAAP Annual Meeting and SymposiumDec 7–10, 2006
   Google Scholar
• BrownESBeardLDobbsLRushAJNaltrexone in patients with bipolar disorder and alcohol dependenceDepress Anxiety20062349249516841344
   PubMed Web of Science ®Google Scholar
• SalloumIMDouaihyACorneliusJRDaleyDCKellyTMKirisciLOpen label randomized pilot study of combined naltrexone and valproate in bipolar alcoholicsAlcohol Clin Exp Res200630140A16433742
   PubMed Web of Science ®Google Scholar
• ReouxJPSaxonAJMalteCABaerJSSloanKLDivalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trialAlcohol Clin Exp Res2001251324132911584152
   PubMed Web of Science ®Google Scholar
• LongoLPCampbellTHubatchSDivalproex sodium (Depakote) for alcohol withdrawal and relapse preventionJ Addict Dis200221556411916372
   PubMed Web of Science ®Google Scholar
• AliyevZNAliyevNAValproate treatment of acute alcohol hallucinosis: a double-blind, placebo-controlled studyAlcohol Alcohol20084345645918495806
   PubMed Web of Science ®Google Scholar
• JohnsonBARosenthalNCapeceJATopiramate for treating alcohol dependence: a randomized controlled trialJAMA20072981641165117925516
   PubMed Web of Science ®Google Scholar
• JohnsonBARosenthalNCapeceJATopiramate for Alcoholism Advisory Board; Topiramate for Alcoholism Study GroupImprovement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trialArch Intern Med20081681188119918541827
   PubMed Web of Science ®Google Scholar
• KushnerSFKhanALaneROlsonWHTopiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trialsBipolar Disord20068152716411977
   PubMed Web of Science ®Google Scholar
• FurieriFANakamura-PalaciosEMGabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trialJ Clin Psychiatry2007681691170018052562
   PubMed Web of Science ®Google Scholar
• MackAExamination of the evidence for off-label use of gabapentinJ Manag Care Pharm2003955956814664664
   PubMedGoogle Scholar
• MartinottiGDi NicolaMDi GiannantonioMJaniriLAripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs naltrexoneJ Psychopharmacol20092312312918515460
   PubMed Web of Science ®Google Scholar
• AntonRFKranzlerHBrederCMarcusRNCarsonWHHanJA randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependenceJ Clin Psychopharmacol20082851218204334
   PubMed Web of Science ®Google Scholar
• DorusWOstrowDGAntonRLithium treatment of depressed and nondepressed alcoholicsJAMA1989262164616522504944
   PubMed Web of Science ®Google Scholar
• DilsaverSCSwannACShoaibAMBowersTCThe manic syndrome: factors which may predict a patient’s response to lithium, carbamazepine and valproateJ Psychiatry Neurosci19931861668461283
   PubMed Web of Science ®Google Scholar
• PettyFGABA and mood disorders: a brief review and hypothesisJ Affective Disord199534275281
   PubMed Web of Science ®Google Scholar
• BrambillaPPerezJBaraleFSchettiniGSoaresJCGABAergic dysfunction in mood disordersMol Psychiatry872173712888801
   PubMed Web of Science ®Google Scholar
• EnochMAThe role of GABAa receptors in the development of alcoholismPharmacol Biochem Behav2008909510418440057
   PubMed Web of Science ®Google Scholar
• VargasCTannhauserMBarrosHMDissimilar effects of lithium and valproic acid on GABA and glutamine concentrations in rat cerebrospinal fluidGen Pharmacol1998306016049522182
   PubMedGoogle Scholar
• ZimmerRTeelkenAWGündürewaMRütherECramerHEffect of sodium-valproate on CSF GABA, cAMP, cGMP and homovanillic acid levels in menBr Res Bull19805Suppl 2585588
   Web of Science ®Google Scholar
• PacchiarottiIMarzoSDColomFSanchez-MorenoJVietaEBipolar disorder preceded by substance abuse: A different phenotype with not so poor outcomeWorld J Biol Psychiatry20071318
   Google Scholar
• HaroJMvan OsJVietaEReedCLorenzoMGoetzIEMBLEM Advisory BoardEvidence for three distinct classes of ‘typical’, ‘psychotic’ and ‘dual’ mania: results from the EMBLEM studyActa Psychiatr Scand200611311212016423162
   PubMed Web of Science ®Google Scholar
• van RossumIHaroJMTenbackDStability and treatment outcome of distinct classes of maniaEur Psychiatry20082336036718434101
   PubMed Web of Science ®Google Scholar
• MerikangasKRAkiskalHSAngstJLifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replicationArch Gen Psychiatry20076454355217485606
   PubMed Web of Science ®Google Scholar
• MerikangasKRHerrellRSwendsenJRösslerWAjdacic-GrossVAngstJSpecificity of bipolar spectrum conditions in the comorbidity of mood and substance use disorders: results from the Zurich cohort studyArch Gen Psychiatry200865475218180428
   PubMed Web of Science ®Google Scholar
• AlbaneseMJClodfelterRCJrPardoTBGhaemiSNUnderdiagnosis of bipolar disorder in men with substance use disorderJ Psychiatr Pract20061212412716728911
   PubMedGoogle Scholar
• BrousseGGarayRPBenyaminaAManagement of comorbid bipolar disorder and alcohol dependencePresse Med2008371132113718296020
   PubMed Web of Science ®Google Scholar